Boyu Hu

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino et al. · New England Journal of Medicine · 2024 · 200 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021

Andrew D. Zelenetz, Leo I. Gordon, Julie Chang et al. · Journal of the National Comprehensive Cancer Network · 2021 · 170 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023

Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson et al. · Journal of the National Comprehensive Cancer Network · 2023 · 117 citations · Full text

Medicine, Hematology, Oncology +17

Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study

Swaminathan P. Iyer, R. Alejandro Sica, P. Joy Ho et al. · The Lancet Oncology · 2024 · 72 citations · Full text

Life Sciences, Immunology, Oncology +15

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide

Koichi Takahashi, Boyu Hu, Feng Wang et al. · Blood · 2018 · 51 citations · Full text

Medicine, Genetics, Oncology +16